Modern nuclear technologies are the so-called high-energy nuclear reactions that can create valuable elements and isotopes through nuclear transformation, but they are incredibly expensive and lead to environmental disasters, and the results are unstable. Therefore, the only industry where atomic fission is used today is energy. At the same time, since ancient times, mankind has been working on another method of obtaining valuable elements and isotopes - low-energy nuclear reactions (LHNR). It is the transformation (transmutation) of certain chemical elements to others in their natural environment, without using a huge amount of energy to split the atom.
The last period of the 20th century and the beginning of the 21st century witnessed a huge breakthrough in such technologies. First, practical evidence of LENR reactions in power engineering was collected, then a self-made low-energy nuclear reactor was built that generates electricity, the facts of nuclear reactions occurring in nature, systematized and studied, and the results of biological nuclear reactions using bacteria were obtained. Today is the time to take the next step - to master the technology for turning cheap elements into valuable elements and isotopes using nuclear reactions with low energy consumption.
The last period of the 20th century and the beginning of the 21st century witnessed a huge breakthrough in such technologies. First, practical evidence of LENR reactions in power engineering was collected, then a self-made low-energy nuclear reactor was built that generates electricity, the facts of nuclear reactions occurring in nature, systematized and studied, and the results of biological nuclear reactions using bacteria were obtained. Today is the time to take the next step - to master the technology for turning cheap elements into valuable elements and isotopes using nuclear reactions with low energy consumption.
At the previous stage of the research, certain processes were discovered that arise during the interaction of metals and energy. A number of know-how have been developed that allow us to talk about great commercial prospects.
Currently, objectively evaluating the results already achieved by the research group "Synthetics" in the field of cold transmutation of elements, we can say with confidence that we have made impressive progress in this area. Without any doubt, having developed our own unique method, we are far ahead of all those who are engaged in this field. The obtained data allow us to assume great commercial prospects for the development of technologies with high added value.
Currently, objectively evaluating the results already achieved by the research group "Synthetics" in the field of cold transmutation of elements, we can say with confidence that we have made impressive progress in this area. Without any doubt, having developed our own unique method, we are far ahead of all those who are engaged in this field. The obtained data allow us to assume great commercial prospects for the development of technologies with high added value.
The purpose of further research of Synthestech is the adaptation of technology and the development of precise methods for the cold transformation of chemical elements; methods that will be commercially profitable and industrially scalable. The work is based on previously obtained data as a result of our own research and the results of studies by other scientists participating in the LENR reactions.
Three main directions of work are planned:
• Transformation of low-value initial elements into valuable elements for obtaining elements such as rhenium, osmium, iridium, platinum, ruthenium, rhodium, palladium and possibly gold;
• Transmutation of low-level initial elements for obtaining non-standard isotope mixtures and individual isotopes of stable elements;
• Transmutation of various initial elements for the production of bioactive elements for medical purposes with properties recorded in sources of ancient Chinese and ancient Indian medicine, as well as in the works of the medieval European scientist and Dr. Paracelsus.
• Transformation of low-value initial elements into valuable elements for obtaining elements such as rhenium, osmium, iridium, platinum, ruthenium, rhodium, palladium and possibly gold;
• Transmutation of low-level initial elements for obtaining non-standard isotope mixtures and individual isotopes of stable elements;
• Transmutation of various initial elements for the production of bioactive elements for medical purposes with properties recorded in sources of ancient Chinese and ancient Indian medicine, as well as in the works of the medieval European scientist and Dr. Paracelsus.
The researchers have the following tasks:
1. To analyze in detail the processes occurring in the reactions previously detected by the Synthestech group;
2. Using the obtained data, select the most technologically and commercially perspective methods of transformation of some elements to others in order to conduct a detailed analysis of the specific cold transformation of chemical elements;
3. Development of optimal conditions for a specific LENR-transmutation reaction;
4. To create and test various modifications of reactors for the cold transformation of chemical elements; the development of structures of equipment, materials, tools, etc.; choose the optimal ratios of the components of the reagent mixture;
5. To make an experimental batch of artificially obtained elements
1. To analyze in detail the processes occurring in the reactions previously detected by the Synthestech group;
2. Using the obtained data, select the most technologically and commercially perspective methods of transformation of some elements to others in order to conduct a detailed analysis of the specific cold transformation of chemical elements;
3. Development of optimal conditions for a specific LENR-transmutation reaction;
4. To create and test various modifications of reactors for the cold transformation of chemical elements; the development of structures of equipment, materials, tools, etc.; choose the optimal ratios of the components of the reagent mixture;
5. To make an experimental batch of artificially obtained elements
OUR EXPERIENCE
We have identified a combination of reagents and compounds of chemical elements that provide the process of cold transmutation, and also developed methods of energy impact that initiate LENR-transmutation. We developed the basic construction of LENR-transmutation equipment. It should be noted that we did not strive to immerse ourselves in theoretical concepts, but focused on empirical methods and practical results.
In a number of experiments we obtained positive results.
Today we have reached such a stage of the development of the project "Cold transmutation of elements", when we already need our modern laboratory with all the necessary equipment that will allow us to determine the finer points of the process, adjust the instruments and go on to pilot production. In addition, it is very important to ensure the confidentiality of our developments and our know-how.
At the moment we have several contracting parties that guarantee us ready markets for our products. Among these products are not only supervalued elements (our contracting parties are ready to sell a number of such elements), but also iron and zinc, since such elements obtained as a result of transmutation have proved to be in demand. Iron and zinc are in demand in medicine as biologically active elements, and for scientific research. Their cost can be much higher than the cost of platinum elements.
We have identified a combination of reagents and compounds of chemical elements that provide the process of cold transmutation, and also developed methods of energy impact that initiate LENR-transmutation. We developed the basic construction of LENR-transmutation equipment. It should be noted that we did not strive to immerse ourselves in theoretical concepts, but focused on empirical methods and practical results.
In a number of experiments we obtained positive results.
Today we have reached such a stage of the development of the project "Cold transmutation of elements", when we already need our modern laboratory with all the necessary equipment that will allow us to determine the finer points of the process, adjust the instruments and go on to pilot production. In addition, it is very important to ensure the confidentiality of our developments and our know-how.
At the moment we have several contracting parties that guarantee us ready markets for our products. Among these products are not only supervalued elements (our contracting parties are ready to sell a number of such elements), but also iron and zinc, since such elements obtained as a result of transmutation have proved to be in demand. Iron and zinc are in demand in medicine as biologically active elements, and for scientific research. Their cost can be much higher than the cost of platinum elements.
STT-TOKENS
At present, we see great opportunities for the further development of LenR technologies and the associated technology of transmutation of elements and isotopes. We invite partners and investors to join the Synthestech laboratory and take part in the Token Generation event (TGE). As part of this event, Synthestech issues tokens on the Ethereum platform and sells them to a wide range of investors for bitcoins and broadcasts. The funds raised will be used for the construction of the Sintechtech laboratory, the formation of a global team of specialists and the conduct of research.
PARAMETERS AND FUNCTIONALITY OF TOKENS The
"Synthestech" (ticker - STT) tokens are dividend chips that give the right to receive 36% of the profits of Swiss SARL isotopes registered in Geneva (Switzerland). The company's profit can be obtained by obtaining royalty from the developed technology for transmutation of LENR or the subsequent launch of production of transmuted elements and isotopes.
From a technical point of view, tokens are equipped with a smart contract for
the Ethereum platform, which complies with the ERC-20 standard, and investors can store them in different wallets and services.
There will be a limited number of STT tokens released during the TGE. The total number and details can be found in terms of selling tokens. There will be no additional issue of the token, ie, the total number of tokens after the TGE can not be increased.
All information about the smart contract will be provided on GitHub and offered to the community to run Bug Bounty before TGE.
"Synthestech" (ticker - STT) tokens are dividend chips that give the right to receive 36% of the profits of Swiss SARL isotopes registered in Geneva (Switzerland). The company's profit can be obtained by obtaining royalty from the developed technology for transmutation of LENR or the subsequent launch of production of transmuted elements and isotopes.
From a technical point of view, tokens are equipped with a smart contract for
the Ethereum platform, which complies with the ERC-20 standard, and investors can store them in different wallets and services.
There will be a limited number of STT tokens released during the TGE. The total number and details can be found in terms of selling tokens. There will be no additional issue of the token, ie, the total number of tokens after the TGE can not be increased.
All information about the smart contract will be provided on GitHub and offered to the community to run Bug Bounty before TGE.
There are many reasons for investing in Synthestech ICO! What can be more reliable than bitcoin, and bring a lot of profit? Synthestech has an answer!
Website: https://ico.synthestech.com/
WhitePaper: https://synthestech.com/White_Paper_en.pdf
Telegram: https://t.me/synthestech
My profile btc : https://bitcointalk.org/index.php?action=profile;u=1567105
Tidak ada komentar:
Posting Komentar